6-Sulfo LacNAc monocytes are quantitatively and functionally disturbed in systemic sclerosis patients

Laure Ricard1,2, Déborah Eshagh1,3, Lama Siblany1,2

  • 1Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.

Summary

Systemic sclerosis patients show increased 6-Sulfo LacNAc monocytes (slanMo), which may drive the expansion of circulating follicular helper T (cTfh) cells, key players in this autoimmune disease.

Related Concept Videos